All In MedTech

Device Trial Radar · NCT05662059

Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis

Investigating the Safety and Efficacy of Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) in Ulcerative Colitis (UC) in Pediatric and Young Adult Populations

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jan 12, 2023

Primary completion

Apr 15, 2026

Study completion Apr 15, 2026

Sponsor

Lead sponsor
Cala Health, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 22, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 10 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, single-center, sham-controlled, double-blinded 12-week study designed to evaluate the safety and efficacy of the RAVANS device in subjects with Ulcerative Colitis. The goal of the study is to distinguish sham (no stimulation) versus treatment (stimulation) response and to identify treatment responders. The study will last 12 weeks with in-clinic visits at 0 weeks and 12 weeks, and a telehealth-visit at week 6. Additionally, unscheduled visits may occur based on the needs of the subject or at the discretion of the investigator. Subjects will be randomized 2:1 to treatment or sham, and will stimulate at home twice per day.

Conditions

  • Ulcerative Colitis

Interventions

  • RAVANSDevice

    Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation

  • RAVANS-shamDevice

    RAVANS sham device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical RemissionTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Feinstein Institute for Medical Research at Northwell Health

    Lake Success, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.